Later, they employed a similar polymeric nanosystem to deliver a cyclooxygenase 1/2 (COX1/2)-targeting PROTAC, and finally reshaped the immunosuppressive tumor microenvironment and reinforced the anti-cancer immunotherapy [225]. Here, PTGS1 is linked to neoplasm.